✦ LIBER ✦

Efficacy and Safety of Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Renal Transplant Recipients: A Single-Center, Retrospective Analysis

✍ Scribed by Dr. Steven Gabardi; Dr. Colm C. Magee; Dr. Steven A. Baroletti; Dr. John A. Powelson; Dr. Jennifer L. Cina; Dr. Anil K. Chandraker

Book ID: 115048907
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 76 KB
Volume: 24
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.24.14.1323.43152

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of low-dose valganci

Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients

✍ Jeong M. Park; Kathleen D. Lake; Juan D. Arenas; Robert J. Fontana 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

The efficacy and safety of valganciclovir (VGCV) for cytomegalovirus (CMV) prophylaxis in liver transplant recipients has not been established. We retrospectively compared the efficacy and safety of low-dose oral VGCV (450 mg once daily for 90 days) and standard oral ganciclovir (1 g three times a d

Efficacy and Safety of Valganciclovir vs

Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

✍ Carlos Paya; Atul Humar; Ed Dominguez; Kenneth Washburn; Emily Blumberg; Barbara 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Cytomegalovirus Infection Prophylaxis Us

Cytomegalovirus Infection Prophylaxis Using Lower Dose Valganciclovir in Cardiac Transplant Patients: A Retrospective Analysis of Efficacy and Safety

✍ Grayburn, Ryan; Anigbogu, Michael; Godden, Jon; Cho, Chi; Zwicke, Dianne; Cheema 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Valganciclovir prophylaxis for cytomegal

Valganciclovir prophylaxis for cytomegalovirus infection in thoracic transplant patients: retrospective study of efficacy, safety, and drug exposure

✍ S. Lefeuvre; P. Chevalier; C. Charpentier; R. Zekkour; L. Havard; M. Benammar; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Efficacy and Safety of Valgancyclovir as

Efficacy and Safety of Valgancyclovir as Preemptive Therapy for the Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

✍ C. Dı́az-Pedroche; C. Lumbreras; P. Del Valle; R. San Juan; S. Hernando; D. Folg 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Randomised trial of efficacy and safety

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients

✍ Edward Gane; Faouzi Saliba; Garcia JC Valdecasas; John O'Grady; Mark D Pescovitz 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 76 KB